Pages that link to "Q33832854"

The following pages link to Fetal hepatic drug elimination (Q33832854):

Displaying 41 items.

• Clinical pharmacology of midazolam in neonates and children: effect of disease-a review (Q27006333) (← links)
• Genetic contribution to variable human CYP3A-mediated metabolism (Q28212042) (← links)
• Maternal urinary bisphenol a during pregnancy and maternal and neonatal thyroid function in the CHAMACOS study (Q28393523) (← links)
• The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. (Q30490602) (← links)
• Liver zonation: Novel aspects of its regulation and its impact on homeostasis (Q33886995) (← links)
• Fetal pharmacotherapy (Q34585150) (← links)
• Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. (Q34626408) (← links)
• Enterohepatic circulation: physiological, pharmacokinetic and clinical implications (Q34774063) (← links)
• Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. (Q34836887) (← links)
• Ontogeny of hepatic and renal systemic clearance pathways in infants: part II. (Q34982129) (← links)
• Key issues in the role of peroxisome proliferator-activated receptor agonism and cell signaling in trichloroethylene toxicity (Q35039302) (← links)
• Pharmacokinetics in the newborn (Q35111481) (← links)
• Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies. (Q35826421) (← links)
• Children's susceptibility to chemicals: a review by developmental stage (Q35977793) (← links)
• Cell-based models to study hepatic drug metabolism and enzyme induction in humans (Q36572634) (← links)
• The fate and effects of xenobiotics in human placenta (Q36835803) (← links)
• Developmental pharmacology: neonates are not just small adults... (Q37127683) (← links)
• Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes (Q37272782) (← links)
• Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. (Q37299378) (← links)
• Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals (Q37409080) (← links)
• Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues (Q37604379) (← links)
• Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid (Q37659046) (← links)
• Phase II drug metabolizing enzymes (Q37776407) (← links)
• Specific features of pharmacokinetics in children. (Q38717340) (← links)
• An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity (Q39043857) (← links)
• Technological challenges of addressing new and more complex migrating products from novel food packaging materials (Q39926132) (← links)
• Interactive effects between CYP1A1 genotypes and environmental polychlorinated dibenzo-p-dioxins and dibenzofurans exposures on liver function profile (Q43330909) (← links)
• Relative importance of maternal and embryonic microsomal epoxide hydrolase in 7,12-dimethylbenz[a]anthracene-induced developmental toxicity (Q43946534) (← links)
• Area/moment and compartmental modeling of pharmacokinetics during pregnancy: applications to maternal/fetal exposures to corticosteroids in sheep and rats (Q45222341) (← links)
• Ontogeny of CYP3A and P-glycoprotein in the liver and the small intestine of the Göttingen minipig: an immunohistochemical evaluation (Q45400881) (← links)
• Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population. (Q45936021) (← links)
• Changes of multiple biotransformation phase I and phase II enzyme activities in human fetal adrenals during fetal development (Q46794510) (← links)
• Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol (Q51732246) (← links)
• Changes to methadone clearance during pregnancy. (Q52288425) (← links)
• Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group. (Q53270128) (← links)
• Metabolic Patterning on a Chip: Towards in vitro Liver Zonation of Primary Rat and Human Hepatocytes. (Q55384558) (← links)
• Dentine biomarkers of prenatal and early childhood exposure to manganese, zinc and lead and childhood behavior (Q57188584) (← links)
• Weight of the Evidence Evaluation of Low-Dose Reproductive and Developmental Effects of Bisphenol A (Q58392333) (← links)
• Novel Pathway of Metabolic Activation of Bisphenol A-Related Compounds for Estrogenic Activity (Q84259505) (← links)
• Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus (Q89690223) (← links)
• Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection (Q94468527) (← links)